World's largest generic drugmaker to slash 14,000 jobs and suspend its dividend
December 14, 2017 at 07:24 AM EST
Teva Pharmaceutical plans to reduce its workforce by 25 percent and suspend its dividend in a much-anticipated overhaul to help pay back its massive debt.
